Oral contraception and the recognition of endometritis

R. B. Ness, L. M. Keder, D. E. Soper, A. J. Amortegui, J. Gluck, H. Wiesenfeld, Richard L Sweet, P. A. Rice, J. F. Peipert, S. P. Donegan, A. Kanbour-Shakir

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

OBJECTIVE: Oral contraceptive use has been associated with a lower risk of symptomatic pelvic inflammatory disease but a higher risk of chlamydial cervicitis. To explain these seemingly contradictory findings, we asked whether oral contraceptive use was more common among women with unrecognized endometritis than among women with recognized endometritis. STUDY DESIGN: A multicenter case-control study was performed. Women without signs of pelvic inflammatory disease were ascertained through contact tracing of partners with sexually transmitted diseases or through presentation with cervicitis. Women with symptomatic pelvic inflammatory disease met a set of standard clinical criteria. We compared the 43 cases without signs of pelvic inflammatory disease but with endometritis ('unrecognized endometritis') with the 111 controls with recognized pelvic inflammatory disease and endometritis ('recognized endometritis'). RESULTS: Women with unrecognized endometritis were 4.3 times (95% confidence interval 1.6 to 11.7) more likely than women with recognized endometritis to use oral contraceptives. CONCLUSION: Future studies need to fully characterize the risks and benefits of oral contraceptives in relation to sexually transmitted diseases.

Original languageEnglish (US)
Pages (from-to)580-585
Number of pages6
JournalAmerican Journal of Obstetrics and Gynecology
Volume176
Issue number3
DOIs
StatePublished - 1997
Externally publishedYes

Fingerprint

Endometritis
Contraception
Pelvic Inflammatory Disease
Oral Contraceptives
Uterine Cervicitis
Sexually Transmitted Diseases
Contact Tracing
Case-Control Studies
Confidence Intervals

Keywords

  • Adnexitis
  • chlamydia
  • contraception
  • gonorrhea

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Ness, R. B., Keder, L. M., Soper, D. E., Amortegui, A. J., Gluck, J., Wiesenfeld, H., ... Kanbour-Shakir, A. (1997). Oral contraception and the recognition of endometritis. American Journal of Obstetrics and Gynecology, 176(3), 580-585. https://doi.org/10.1016/S0002-9378(97)70551-9

Oral contraception and the recognition of endometritis. / Ness, R. B.; Keder, L. M.; Soper, D. E.; Amortegui, A. J.; Gluck, J.; Wiesenfeld, H.; Sweet, Richard L; Rice, P. A.; Peipert, J. F.; Donegan, S. P.; Kanbour-Shakir, A.

In: American Journal of Obstetrics and Gynecology, Vol. 176, No. 3, 1997, p. 580-585.

Research output: Contribution to journalArticle

Ness, RB, Keder, LM, Soper, DE, Amortegui, AJ, Gluck, J, Wiesenfeld, H, Sweet, RL, Rice, PA, Peipert, JF, Donegan, SP & Kanbour-Shakir, A 1997, 'Oral contraception and the recognition of endometritis', American Journal of Obstetrics and Gynecology, vol. 176, no. 3, pp. 580-585. https://doi.org/10.1016/S0002-9378(97)70551-9
Ness RB, Keder LM, Soper DE, Amortegui AJ, Gluck J, Wiesenfeld H et al. Oral contraception and the recognition of endometritis. American Journal of Obstetrics and Gynecology. 1997;176(3):580-585. https://doi.org/10.1016/S0002-9378(97)70551-9
Ness, R. B. ; Keder, L. M. ; Soper, D. E. ; Amortegui, A. J. ; Gluck, J. ; Wiesenfeld, H. ; Sweet, Richard L ; Rice, P. A. ; Peipert, J. F. ; Donegan, S. P. ; Kanbour-Shakir, A. / Oral contraception and the recognition of endometritis. In: American Journal of Obstetrics and Gynecology. 1997 ; Vol. 176, No. 3. pp. 580-585.
@article{f0ae47cdd5b14b31934da7f72886921e,
title = "Oral contraception and the recognition of endometritis",
abstract = "OBJECTIVE: Oral contraceptive use has been associated with a lower risk of symptomatic pelvic inflammatory disease but a higher risk of chlamydial cervicitis. To explain these seemingly contradictory findings, we asked whether oral contraceptive use was more common among women with unrecognized endometritis than among women with recognized endometritis. STUDY DESIGN: A multicenter case-control study was performed. Women without signs of pelvic inflammatory disease were ascertained through contact tracing of partners with sexually transmitted diseases or through presentation with cervicitis. Women with symptomatic pelvic inflammatory disease met a set of standard clinical criteria. We compared the 43 cases without signs of pelvic inflammatory disease but with endometritis ('unrecognized endometritis') with the 111 controls with recognized pelvic inflammatory disease and endometritis ('recognized endometritis'). RESULTS: Women with unrecognized endometritis were 4.3 times (95{\%} confidence interval 1.6 to 11.7) more likely than women with recognized endometritis to use oral contraceptives. CONCLUSION: Future studies need to fully characterize the risks and benefits of oral contraceptives in relation to sexually transmitted diseases.",
keywords = "Adnexitis, chlamydia, contraception, gonorrhea",
author = "Ness, {R. B.} and Keder, {L. M.} and Soper, {D. E.} and Amortegui, {A. J.} and J. Gluck and H. Wiesenfeld and Sweet, {Richard L} and Rice, {P. A.} and Peipert, {J. F.} and Donegan, {S. P.} and A. Kanbour-Shakir",
year = "1997",
doi = "10.1016/S0002-9378(97)70551-9",
language = "English (US)",
volume = "176",
pages = "580--585",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Oral contraception and the recognition of endometritis

AU - Ness, R. B.

AU - Keder, L. M.

AU - Soper, D. E.

AU - Amortegui, A. J.

AU - Gluck, J.

AU - Wiesenfeld, H.

AU - Sweet, Richard L

AU - Rice, P. A.

AU - Peipert, J. F.

AU - Donegan, S. P.

AU - Kanbour-Shakir, A.

PY - 1997

Y1 - 1997

N2 - OBJECTIVE: Oral contraceptive use has been associated with a lower risk of symptomatic pelvic inflammatory disease but a higher risk of chlamydial cervicitis. To explain these seemingly contradictory findings, we asked whether oral contraceptive use was more common among women with unrecognized endometritis than among women with recognized endometritis. STUDY DESIGN: A multicenter case-control study was performed. Women without signs of pelvic inflammatory disease were ascertained through contact tracing of partners with sexually transmitted diseases or through presentation with cervicitis. Women with symptomatic pelvic inflammatory disease met a set of standard clinical criteria. We compared the 43 cases without signs of pelvic inflammatory disease but with endometritis ('unrecognized endometritis') with the 111 controls with recognized pelvic inflammatory disease and endometritis ('recognized endometritis'). RESULTS: Women with unrecognized endometritis were 4.3 times (95% confidence interval 1.6 to 11.7) more likely than women with recognized endometritis to use oral contraceptives. CONCLUSION: Future studies need to fully characterize the risks and benefits of oral contraceptives in relation to sexually transmitted diseases.

AB - OBJECTIVE: Oral contraceptive use has been associated with a lower risk of symptomatic pelvic inflammatory disease but a higher risk of chlamydial cervicitis. To explain these seemingly contradictory findings, we asked whether oral contraceptive use was more common among women with unrecognized endometritis than among women with recognized endometritis. STUDY DESIGN: A multicenter case-control study was performed. Women without signs of pelvic inflammatory disease were ascertained through contact tracing of partners with sexually transmitted diseases or through presentation with cervicitis. Women with symptomatic pelvic inflammatory disease met a set of standard clinical criteria. We compared the 43 cases without signs of pelvic inflammatory disease but with endometritis ('unrecognized endometritis') with the 111 controls with recognized pelvic inflammatory disease and endometritis ('recognized endometritis'). RESULTS: Women with unrecognized endometritis were 4.3 times (95% confidence interval 1.6 to 11.7) more likely than women with recognized endometritis to use oral contraceptives. CONCLUSION: Future studies need to fully characterize the risks and benefits of oral contraceptives in relation to sexually transmitted diseases.

KW - Adnexitis

KW - chlamydia

KW - contraception

KW - gonorrhea

UR - http://www.scopus.com/inward/record.url?scp=0030992965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030992965&partnerID=8YFLogxK

U2 - 10.1016/S0002-9378(97)70551-9

DO - 10.1016/S0002-9378(97)70551-9

M3 - Article

C2 - 9077610

AN - SCOPUS:0030992965

VL - 176

SP - 580

EP - 585

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 3

ER -